Tethering: Fragment-based drug discovery by mass Spectrometry

Mass Spectrometry in Medicinal Chemistry

Volumn 36, Issue , 2007, Pages 303-320

  Cancilla, Mark T ^a   Erlanson, Daniel A ^a  

^a Sunesis Pharmaceuticals Inc   (United States)

Author keywords

Advantages; Caspase 1; Caspase 3; Finding fragments; Fragment based drug discovery by mass spectrometry; Technique

Indexed keywords

MASS SPECTROMETRY;

ADVANTAGES; CASPASE-1; CASPASE-3; DRUG DISCOVERY; FINDING FRAGMENTS; TECHNIQUE;

DRUG PRODUCTS;

EID: 35348861993     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527610907.ch9     Document Type: Chapter

References (36)

1. Erlanson, D.A., McDowell, R.S., O'Brien, T.: Fragment-based drug discovery. J. Med. Chem. 2004, 47, 3463-3482.
2. Rees, D.C., Congreve, M., Murray, C.W., Carr, R.: Fragment-based lead discovery. Nat. Rev. Drug Discov. 2004, 3, 660-672.
3. Jahnke, W., Erlanson, D.A. (Eds): Fragment-Based Approaches in Drug Discovery. Vol 34 in series Methods and Principles in Medicinal Chemistry (Series Eds: R. Mannhold, H. Kubinyi, G. Folkers). Weinheim, Germany: Wiley-VCH; 2006.
4. Lipinski, C.A.H., All, L.: Navigating chemical space for biology and medicine. Nature 2004, 432, 855-861.
5. Maly, D.J., Choong, I.C., Ellman, J.A.: Combinatorial target-guided ligand assembly: identification of potent subtype-selective c-Src inhibitors. Proc. Natl Acad. Sci. USA 2000, 97, 2419-2424.
6. Shuker, S.B., Hajduk, P.J., Meadows, R. P., Fesik, S.W.: Discovering high-affinity ligands for proteins: SAR by NMR. Science 1996, 274, 1531-1534.
7. Hajduk, P.J., Gerfin, T., Boehlen, J.M., Haberli, M., Marek, D., Fesik, S. W.: High-throughput nuclear magnetic resonance-based screening. J. Med. Chem. 1999, 42, 2315-2317.
8. Huth, J.R., Sun, C.: Utility of NMR in lead optimization: fragment-based approaches. Comb. Chem. High. Throughput Screen. 2002, 5, 631-643.
9. Nienaber, V.L., Richardson, P.L., Klighofer, V., Bouska, J.J., Giranda, V.L., Greer, J.: Discovering novel ligands for macromolecules using X-ray crystallographic screening. Nat. Biotechnol. 2000, 18, 1105-1108.
10. Congreve, M.S., Davis, D.J., Devine, L. , Granata, C., O'Reilly, M., Wyatt, P.G., Jhoti, H.: Detection of ligands from a dynamic combinatorial library by X-ray crystallography. Angew. Chem. Int. Ed. Engl. 2003, 42, 4479-4482.
11. Erlanson, D.A., Braisted, A.C., Raphael, D.R., Randal, M., Stroud, R.M., Gordon, E.M., Wells, J.A.: Site-directed ligand discovery. Proc. Natl Acad. Sci. USA 2000, 97, 9367-9372.
12. Erlanson, D.A., Wells, J.A., Braisted, A.C.: Tethering: fragment-based drug discovery. Annu. Rev. Biophys. Biomol. Struct. 2004, 33, 199-223.
13. Hofstadler, S.A., Griffey, R.H.: Analysis of noncovalent complexes of DNA and RNA by mass spectrometry. Chem. Rev. 2001, 101, 377-390.
14. Swayze, E.E., Jefferson, E.A., Sannes-Lowery, K.A., Blyn, L.B., Risen, L.M., Arakawa, S., Osgood, S.A., Hofstadler, S.A., Griffey, R.H.: SAR by MS: a ligand based technique for drug lead discovery against structured RNA targets. J. Med. Chem. 2002, 45, 3816-3819.
15. Ockey, D.A., Dotson, J.L., Struble, M. E., Stults, J.T., Bourell, J.H., Clark, K.R., Gadek, T.R.: Structure-activity relationships by mass spectrometry: identification of novel MMP-3 inhibitors. Bioorg. Med. Chem. 2004, 12, 37-44.
16. Whitehouse, C.M., Dreyer, R.N., Yamashita, M., Fenn, J.B.:Electrospray interface for liquid chromatographs and mass spectrometers. Anal. Chem. 1985, 57, 675-679.
17. Karas, M., Bachmann, D., Hillenkamp, F.: Influence of the wavelength in high-irradiance ultraviolet laser desorption mass spectrometry of organic molecules. Anal. Chem. 1985, 57, 2935-2939.
18. Annis, D.A., Nazef, N., Chuang, C.C., Scott, M.P., Nash, H.M.: A general technique to rank protein-ligand binding affinities and determine allosteric versus direct binding site competition in compound mixtures. J. Am. Chem. Soc. 2004, 126, 15495-15503.
19. Tethering is a registered service mark of Sunesis Pharmaceuticals, Inc., for its fragment-based drug discovery.
20. Erlanson, D.A., Ballinger, M.D., Wells, J.A.: Tethering, in Fragment-based Approaches in Drug Discovery, ed. W. Jahnke, D.A. Erlanson, Wiley-VCH, Weinheim, 2006. pp 285-310.
21. Keire, D.A., Strauss, E., Guo, W., Noszál, B., Rabenstein, D.L.: Kinetics and equilibria of thiol/disulfide interchange reactions of selected biological thiols and related molecules with oxidized glutathione. J. Org. Chem. 1992, 57, 123-127.
22. McGovern, S.L., Caselli, E., Grigorieff, N., Shoichet, B.K.: A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening. J. Med. Chem. 2002, 45, 1712-1722.
23. Costi, M.P., Tondi, D., Rinaldi, M., Barlocco, D., Pecorari, P., Soragni, F., Venturelli, A., Stroud, R.M.: Structure-based studies on species-specific inhibition of thymidylate synthase. Biochim. Biophys. Acta 2002, 1587, 206-214.
24. Erlanson, D.A., Lam, J.W., Wiesmann, C., Luong, T.N., Simmons, R.L., DeLano, W.L., Choong, I.C., Burdett, M.T., Flanagan, W.M., Lee, D., Gordon, E.M., O'Brien, T.: In situ assembly of enzyme inhibitors using extended tethering. Nat. Biotechnol. 2003, 21, 308-314.
25. O'Brien, T., Lee, D.: Prospects for caspase inhibitors. Mini Rev. Med. Chem. 2004, 4, 153-165.
26. Choong, I.C., Lew, W., Lee, D., Pham, P., Burdett, M.T., Lam, J.W., Wiesmann, C., Luong, T.N., Fahr, B., DeLano, W.L., McDowell, R.S., Allen, D.A., Erlanson, D.A., Gordon, E.M., O'Brien, T.: Identification of potent and selective small-molecule inhibitors of caspase-3 through the use of extended tethering and structure-based drug design. J. Med. Chem. 2002, 45, 5005-5022.
27. Allen, D.A., Pham, P., Choong, I.C., Fahr, B., Burdett, M.T., Lew, W., DeLano, W.L., Gordon, E.M., Lam, J.W., O'Brien, T., Lee, D.: Identification of potent and novel small-molecule inhibitors of caspase-3. Bioorg. Med. Chem. Lett. 2003, 13, 3651-3655.
28. O'Brien, T., Fahr, B.T., Sopko, M., Lam, J.W., Waal, N.D., Raimundo, B.C., Purkey, H., Pham, P., Romanowski, M.J.: Structural analysis of caspase-1 inhibitors derived from Tethering. Acta Crystallogr. 2005, F61, 451-458.
29. Fahr, B.T., O'Brien, T., Pham, P., Waal, N.D., Baskaran, S., Raimundo, B.C., Lam, J.W., Sopko, M.M., Purkey, H.E., Romanowski, M.J.: Tethering identifies fragment that yields potent inhibitors of human caspase-1. Bioorg. Med. Chem. Lett. 2006, 16, 559-562.
30. Thornberry, N.A., Rano, T.A., Peterson, E.P., Rasper, D.M., Timkey, T., Garcia-Calvo, M., Houtzager, V., Nordstrom, P., Roy, S., Vaillancourt, J., Chapman, K., Nicholson, D.: A combinatorial approach defines specificities of members of the caspase family and Granzyme B. J. Biol. Chem. 1997, 272, 17907-17911.
31. Braisted, A.C., Oslob, J.D., Delano, W.L., Hyde, J., McDowell, R.S., Waal, N., Yu, C., Arkin, M.R., Raimundo, B.C.: Discovery of a potent small molecule IL-2 inhibitor through fragment assembly. J. Am. Chem. Soc. 2003, 125, 3714-3715.
32. Arkin, M.R., Randal, M., DeLano, W.L., Hyde, J., Luong, T.N., Oslob, J.D., Raphael, D.R., Taylor, L., Wang, J., McDowell, R.S., Wells, J.A., Braisted, A.C.: Binding of small molecules to an adaptive protein-protein interface. Proc. Natl Acad. Sci. USA 2003, 100, 1603-1608.
33. Raimundo, B.C., Oslob, J.D., Braisted, A.C., Hyde, J., McDowell, R.S., Randal, M., Waal, N.D., Wilkinson, J., Yu, C.H., Arkin, M.R.: Integrating fragment assembly and biophysical methods in the chemical advancement of small-molecule antagonists of IL-2: an approach for inhibiting protein-protein interactions. J. Med. Chem. 2004, 47, 3111-3130.
34. Hardy, J.A., Lam, J., Nguyen, J.T., O'Brien, T., Wells, J.A.: Discovery of an allosteric site in the caspases. Proc. Natl Acad. Sci. USA 2004, 101, 12461-12466.
35. Buck, E., Wells, J.A.: Disulfide trapping to localize small-molecule agonists and antagonists for a G protein-coupled receptor. Proc. Natl Acad. Sci. USA 2005, 102, 2719-2724.
36. Buck, E., Bourne, H., Wells, J.A.: Site-specific disulfide capture of agonist and antagonist peptides on the C5a receptor. J. Biol. Chem. 2005, 280, 4009-4012.